These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15882534)

  • 21. [Incidence of influenza and influenza vaccine effectiveness in the 2004-2005 season].
    Castilla J; Arregui L; Baleztena J; Barricarte A; Brugos A; Carpintero M; Cortés F; Chérrez C; Díez J; Fernández-Alonso M; Figuerido E; Franco T; Gil A; Guijarro JL; Iceta A; Lacalle MT; Martín C; Martínez Mazo MD; Morán J; Moreno M; Palau J; Pérez-Afonso F; Rodríguez Macías A; Ruiz I; Senosiain MA; Sota M; Virto T; Vizcay JM; Yoldi C; Zubicoa J;
    An Sist Sanit Navar; 2006; 29(1):97-106. PubMed ID: 16670732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization.
    Zerr DM; Englund JA; Robertson AS; Marcuse EK; Garrison MM; Christakis DA
    Pediatrics; 2008 Feb; 121(2):345-8. PubMed ID: 18245426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection.
    Finelli L; Fiore A; Dhara R; Brammer L; Shay DK; Kamimoto L; Fry A; Hageman J; Gorwitz R; Bresee J; Uyeki T
    Pediatrics; 2008 Oct; 122(4):805-11. PubMed ID: 18829805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccination among Canadians with chronic respiratory disease.
    Vozoris NT; Lougheed MD
    Respir Med; 2009 Jan; 103(1):50-8. PubMed ID: 18818066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(33):913-8. PubMed ID: 19713879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long time trends in influenza-like illness and associated determinants in The Netherlands.
    Dijkstra F; Donker GA; Wilbrink B; Van Gageldonk-Lafeber AB; Van Der Sande MA
    Epidemiol Infect; 2009 Apr; 137(4):473-9. PubMed ID: 18789176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1091-5. PubMed ID: 19816396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.
    Louie JK; Schechter R; Honarmand S; Guevara HF; Shoemaker TR; Madrigal NY; Woodfill CJ; Backer HD; Glaser CA
    Pediatrics; 2006 Apr; 117(4):e610-8. PubMed ID: 16585278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    McMahon AW; Iskander JK; Haber P; Braun MM; Ball R
    Vaccine; 2008 Jan; 26(3):427-9. PubMed ID: 18093701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse reactions to different types of influenza vaccines].
    Bernad Valles M; Núñez Mateos JC; Castillo Soria O; González Manjavacas MC; García Serna B
    Med Clin (Barc); 1996 Jan; 106(1):11-4. PubMed ID: 8750535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-specific influenza vaccination coverage among adults aged > or =18 years--United States, 2003-04 and 2005-06 influenza seasons.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):953-9. PubMed ID: 17882124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.